These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

602 related items for PubMed ID: 23887641

  • 1. Pharmacological inhibition of the chemokine receptor, CX3CR1, reduces atherosclerosis in mice.
    Poupel L, Boissonnas A, Hermand P, Dorgham K, Guyon E, Auvynet C, Charles FS, Lesnik P, Deterre P, Combadiere C.
    Arterioscler Thromb Vasc Biol; 2013 Oct; 33(10):2297-305. PubMed ID: 23887641
    [Abstract] [Full Text] [Related]

  • 2. Deficiency in lymphotoxin β receptor protects from atherosclerosis in apoE-deficient mice.
    Grandoch M, Feldmann K, Göthert JR, Dick LS, Homann S, Klatt C, Bayer JK, Waldheim JN, Rabausch B, Nagy N, Oberhuber A, Deenen R, Köhrer K, Lehr S, Homey B, Pfeffer K, Fischer JW.
    Circ Res; 2015 Apr 10; 116(8):e57-68. PubMed ID: 25740843
    [Abstract] [Full Text] [Related]

  • 3. Foamy monocytes form early and contribute to nascent atherosclerosis in mice with hypercholesterolemia.
    Xu L, Dai Perrard X, Perrard JL, Yang D, Xiao X, Teng BB, Simon SI, Ballantyne CM, Wu H.
    Arterioscler Thromb Vasc Biol; 2015 Aug 10; 35(8):1787-97. PubMed ID: 26112011
    [Abstract] [Full Text] [Related]

  • 4. Loss of Macrophage Low-Density Lipoprotein Receptor-Related Protein 1 Confers Resistance to the Antiatherogenic Effects of Tumor Necrosis Factor-α Inhibition.
    Zhu L, Giunzioni I, Tavori H, Covarrubias R, Ding L, Zhang Y, Ormseth M, Major AS, Stafford JM, Linton MF, Fazio S.
    Arterioscler Thromb Vasc Biol; 2016 Aug 10; 36(8):1483-95. PubMed ID: 27365402
    [Abstract] [Full Text] [Related]

  • 5. Attenuation of early atherogenesis in low-density lipoprotein receptor-deficient mice by proteasome inhibition.
    Wilck N, Fechner M, Dreger H, Hewing B, Arias A, Meiners S, Baumann G, Stangl V, Stangl K, Ludwig A.
    Arterioscler Thromb Vasc Biol; 2012 Jun 10; 32(6):1418-26. PubMed ID: 22516063
    [Abstract] [Full Text] [Related]

  • 6. The anti-inflammatory vasostatin-2 attenuates atherosclerosis in ApoE-/- mice and inhibits monocyte/macrophage recruitment.
    Xiong W, Wang X, Dai D, Zhang B, Lu L, Tao R.
    Thromb Haemost; 2017 Jan 26; 117(2):401-414. PubMed ID: 27831589
    [Abstract] [Full Text] [Related]

  • 7. KRP-203, sphingosine 1-phosphate receptor type 1 agonist, ameliorates atherosclerosis in LDL-R-/- mice.
    Potì F, Gualtieri F, Sacchi S, Weißen-Plenz G, Varga G, Brodde M, Weber C, Simoni M, Nofer JR.
    Arterioscler Thromb Vasc Biol; 2013 Jul 26; 33(7):1505-12. PubMed ID: 23640484
    [Abstract] [Full Text] [Related]

  • 8. P2Y6 deficiency limits vascular inflammation and atherosclerosis in mice.
    Stachon P, Peikert A, Michel NA, Hergeth S, Marchini T, Wolf D, Dufner B, Hoppe N, Ayata CK, Grimm M, Cicko S, Schulte L, Reinöhl J, von zur Muhlen C, Bode C, Idzko M, Zirlik A.
    Arterioscler Thromb Vasc Biol; 2014 Oct 26; 34(10):2237-45. PubMed ID: 25104800
    [Abstract] [Full Text] [Related]

  • 9. Omega-3 fatty acids ameliorate atherosclerosis by favorably altering monocyte subsets and limiting monocyte recruitment to aortic lesions.
    Brown AL, Zhu X, Rong S, Shewale S, Seo J, Boudyguina E, Gebre AK, Alexander-Miller MA, Parks JS.
    Arterioscler Thromb Vasc Biol; 2012 Sep 26; 32(9):2122-30. PubMed ID: 22814747
    [Abstract] [Full Text] [Related]

  • 10. Histamine H1 receptor promotes atherosclerotic lesion formation by increasing vascular permeability for low-density lipoproteins.
    Rozenberg I, Sluka SH, Rohrer L, Hofmann J, Becher B, Akhmedov A, Soliz J, Mocharla P, Borén J, Johansen P, Steffel J, Watanabe T, Lüscher TF, Tanner FC.
    Arterioscler Thromb Vasc Biol; 2010 May 26; 30(5):923-30. PubMed ID: 20203300
    [Abstract] [Full Text] [Related]

  • 11. Apolipoprotein A-I protection against atherosclerosis is dependent on genetic background.
    Sontag TJ, Krishack PA, Lukens JR, Bhanvadia CV, Getz GS, Reardon CA.
    Arterioscler Thromb Vasc Biol; 2014 Feb 26; 34(2):262-9. PubMed ID: 24334873
    [Abstract] [Full Text] [Related]

  • 12. Effect of S-aspirin, a novel hydrogen-sulfide-releasing aspirin (ACS14), on atherosclerosis in apoE-deficient mice.
    Zhang H, Guo C, Zhang A, Fan Y, Gu T, Wu D, Sparatore A, Wang C.
    Eur J Pharmacol; 2012 Dec 15; 697(1-3):106-16. PubMed ID: 23085268
    [Abstract] [Full Text] [Related]

  • 13. A novel small molecule liver X receptor transcriptional regulator, nagilactone B, suppresses atherosclerosis in apoE-deficient mice.
    Gui Y, Yao S, Yan H, Hu L, Yu C, Gao F, Xi C, Li H, Ye Y, Wang Y.
    Cardiovasc Res; 2016 Oct 15; 112(1):502-14. PubMed ID: 27460841
    [Abstract] [Full Text] [Related]

  • 14. Role of Hic-5 in the formation of microvilli-like structures and the monocyte-endothelial interaction that accelerates atherosclerosis.
    Arita-Okubo S, Kim-Kaneyama JR, Lei XF, Fu WG, Ohnishi K, Takeya M, Miyauchi A, Honda H, Itabe H, Miyazaki T, Miyazaki A.
    Cardiovasc Res; 2015 Mar 01; 105(3):361-71. PubMed ID: 25587044
    [Abstract] [Full Text] [Related]

  • 15. Corosolic acid ameliorates atherosclerosis in apolipoprotein E-deficient mice by regulating the nuclear factor-κB signaling pathway and inhibiting monocyte chemoattractant protein-1 expression.
    Chen H, Yang J, Zhang Q, Chen LH, Wang Q.
    Circ J; 2012 Mar 01; 76(4):995-1003. PubMed ID: 22293444
    [Abstract] [Full Text] [Related]

  • 16. Local delivery of IL-2 reduces atherosclerosis via expansion of regulatory T cells.
    Dietrich T, Hucko T, Schneemann C, Neumann M, Menrad A, Willuda J, Atrott K, Stibenz D, Fleck E, Graf K, Menssen HD.
    Atherosclerosis; 2012 Feb 01; 220(2):329-36. PubMed ID: 22062588
    [Abstract] [Full Text] [Related]

  • 17. EphA2 knockdown attenuates atherosclerotic lesion development in ApoE(-/-) mice.
    Jiang H, Li X, Zhang X, Liu Y, Huang S, Wang X.
    Cardiovasc Pathol; 2014 Feb 01; 23(3):169-74. PubMed ID: 24561077
    [Abstract] [Full Text] [Related]

  • 18. Attenuation of experimental atherosclerosis by interleukin-19.
    Ellison S, Gabunia K, Kelemen SE, England RN, Scalia R, Richards JM, Orr AW, Traylor JG, Rogers T, Cornwell W, Berglund LM, Goncalves I, Gomez MF, Autieri MV.
    Arterioscler Thromb Vasc Biol; 2013 Oct 01; 33(10):2316-24. PubMed ID: 23950143
    [Abstract] [Full Text] [Related]

  • 19. Activation of Adiponectin Receptor Regulates Proprotein Convertase Subtilisin/Kexin Type 9 Expression and Inhibits Lesions in ApoE-Deficient Mice.
    Sun L, Yang X, Li Q, Zeng P, Liu Y, Liu L, Chen Y, Yu M, Ma C, Li X, Li Y, Zhang R, Zhu Y, Miao QR, Han J, Duan Y.
    Arterioscler Thromb Vasc Biol; 2017 Jul 01; 37(7):1290-1300. PubMed ID: 28546220
    [Abstract] [Full Text] [Related]

  • 20. Insulin-Like Growth Factor-1 Receptor Deficiency in Macrophages Accelerates Atherosclerosis and Induces an Unstable Plaque Phenotype in Apolipoprotein E-Deficient Mice.
    Higashi Y, Sukhanov S, Shai SY, Danchuk S, Tang R, Snarski P, Li Z, Lobelle-Rich P, Wang M, Wang D, Yu H, Korthuis R, Delafontaine P.
    Circulation; 2016 Jun 07; 133(23):2263-78. PubMed ID: 27154724
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 31.